Skip to main content

Dr. Robert Emery Disputes Joe Mangano's Findings on Radiation and Fukushima

Just a few minutes ago, I received the following statement from Dr. Robert Emery, Vice President for Safety, Health, Environment & Risk Management at the University of Texas Health Science Center at Houston concerning Dr. Joseph Mangano's recent study on fallout from the Fukushima Daiichi nuclear energy facility reaching the U.S.
“We aggressively monitored for the presence of environmental radioactivity in Houston following the Fukushima event and worked closely with local public health authorities in the event we detected any threat to public health. We never detected any elevated radiation levels. I don’t see any evidence to supports the assertion made by this report that the additional 484 deaths in Houston in 2011 could in any way be related to radioactivity from Fukushima - we never detected any.”

"Moreover the study bases its conclusion on the comparison of data from deaths in the U.S. in 2010 and 2011. Using this method you really can’t determine the specific cause of any increase in deaths over the two years. Perhaps the most important question is: what did the 148,395 U.S. citizens die of in 2010, the year before the Japanese earthquake? Most likely the overwhelming causes were heart disease, cancer, and stroke. I believe this is likely the case in 2011 as well. I also believe our finite public health resources are better spent on the issues we know are causing people to die rather than being diverted to explore hypothetical projections"
It ought to be clear by now that Mangano's claims are being broadly discredited by the wider scientific community. Click here, here and here for our recent posts on how independent 3rd party voices are warning the public to disregard Mangano's research.

Comments

Tom Blees said…
You're being charitable to call Mangano's absurdities "research". The guy's a charlatan, plain and simple.

Popular posts from this blog

Fluor Invests in NuScale

You know, it’s kind of sad that no one is willing to invest in nuclear energy anymore. Wait, what? NuScale Power celebrated the news of its company-saving $30 million investment from Fluor Corp. Thursday morning with a press conference in Washington, D.C. Fluor is a design, engineering and construction company involved with some 20 plants in the 70s and 80s, but it has not held interest in a nuclear energy company until now. Fluor, which has deep roots in the nuclear industry, is betting big on small-scale nuclear energy with its NuScale investment. "It's become a serious contender in the last decade or so," John Hopkins, [Fluor’s group president in charge of new ventures], said. And that brings us to NuScale, which had run into some dark days – maybe not as dark as, say, Solyndra, but dire enough : Earlier this year, the Securities Exchange Commission filed an action against NuScale's lead investor, The Michael Kenwood Group. The firm "misap...

Wednesday Update

From NEI’s Japan micro-site: NRC, Industry Concur on Many Post-Fukushima Actions Industry/Regulatory/Political Issues • There is a “great deal of alignment” between the U.S. Nuclear Regulatory Commission and the industry on initial steps to take at America’s nuclear energy facilities in response to the nuclear accident in Japan, Charles Pardee, the chief operating officer of Exelon Generation Co., said at an agency briefing today. The briefing gave stakeholders an opportunity to discuss staff recommendations for near-term actions the agency may take at U.S. facilities. PowerPoint slides from the meeting are on the NRC website. • The International Atomic Energy Agency board has approved a plan that calls for inspectors to evaluate reactor safety at nuclear energy facilities every three years. Governments may opt out of having their country’s facilities inspected. Also approved were plans to maintain a rapid response team of experts ready to assist facility operators recoverin...

Nuclear Utility Moves Up in Credit Ratings, Bank is "Comfortable with Nuclear Strategy"

Some positive signs that nuclear utilities can continue to receive positive ratings even while they finance new nuclear plants for the first time in decades: Wells Fargo upgrades SCANA to Outperform from Market Perform Wells analyst says, "YTD, SCG shares have underperformed the Regulated Electrics (total return +2% vs. +9%). Shares trade at 11.3X our 10E EPS, a modest discount to the peer group median of 11.8X. We view the valuation as attractive given a comparatively constructive regulatory environment and potential for above-average long-term EPS growth prospects ... Comfortable with Nuclear Strategy. SCG plans to participate in the development of two regulated nuclear units at a cost of $6.3B, raising legitimate concerns regarding financing and construction. We have carefully considered the risks and are comfortable with SCG’s strategy based on a highly constructive political & regulatory environment, manageable financing needs stretched out over 10 years, strong partners...